Company Profile

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE368.30-0.2 (-0.05 % )
PREV CLOSE (Rs.) 368.50
OPEN PRICE (Rs.) 372.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 322
TODAY'S LOW / HIGH (Rs.)367.00 372.40
52 WK LOW / HIGH (Rs.)341.05 643.75
NSE372.40 3.5 (+0.95 % )
PREV CLOSE(Rs.) 368.90
OPEN PRICE (Rs.) 377.55
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 18811
TODAY'S LOW / HIGH(Rs.) 365.05 385.00
52 WK LOW / HIGH (Rs.)321 644

Board Meetings

Source Date Board Meeting Date Details
05-Mar-2020 11-Mar-2020 Interim Dividend
07-Feb-2020 14-Feb-2020 Quarterly Results
24-Oct-2019 07-Nov-2019 Quarterly Results
22-Jul-2019 27-Jul-2019 Quarterly Results
24-Jun-2019 03-Jul-2019 Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/07/2019 ,inter alia, to consider and approve We hereby inform that the Board of Directors will consider a proposal of buyback of the fully paid-up equity shares of the Company of face value of Re. 1/- each at its meeting scheduled to be held on 3rd July, 2019. The outcome of the Board Meeting will be disseminated to stock exchanges after conclusion of the Board Meeting on 3rd July, 2019. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Policy on 'Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company'', the Trading Window of the Company shall remain closed from 25th June, 2019 to 5th July, 2019 (Both Days Inclusive).
14-May-2019 21-May-2019 Audited Results
21-Jan-2019 29-Jan-2019 Quarterly Results
25-Oct-2018 03-Nov-2018 ERIS LIFESCIENCES LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2018 ,inter alia, to consider and approve NOTICE IS HEREBY given that a Meeting of the Board of Directors of Eris Lifesciences Limited ('the Company') is scheduled to be held on Saturday, 3rd November, 2018 to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / half year ended 30th September, 2018. Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on 'Code of conduct to regulate, monitor and report trading by Insiders' of the Company, the Trading Window for dealing in shares of the Company will remain closed from 26th October, 2018 to 5th November, 2018 (both days inclusive) for the purpose of this Board Meeting.
01-Aug-2018 09-Aug-2018 Quarterly Results
15-May-2018 25-May-2018 NOTICE IS HEREBY given that a Meeting of the Board of Directors of Eris Lifesciences Limited ('the Company') is scheduled to be held on Friday, May 25, 2018, to, inter alia, consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2018. Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on 'code of conduct to regulate, monitor and report trading by Insiders' of the Company, the Trading Window for dealing in shares of the Company will remain closed from May 15, 2018 to May 27, 2018 (both days inclusive) for the purpose of this Board Meeting and the same has been notified to the Designated Persons.